Suppr超能文献

体内重编程治疗心脏病。

In vivo reprogramming for heart disease.

机构信息

1] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.

出版信息

Cell Res. 2012 Nov;22(11):1521-3. doi: 10.1038/cr.2012.101. Epub 2012 Jul 3.

Abstract

The term "lineage reprogramming" is typically used to describe the conversion of one differentiated somatic cell type into another without transit through a pluripotent intermediate. Two recent reports in Nature demonstrate that such a conversion can be achieved in the heart in situ, and suggest a novel, regenerative approach for the development of cardiac therapeutics.

摘要

“谱系重编程”一词通常用于描述一种分化的体细胞类型在不经过多能中间状态的情况下转化为另一种类型。《自然》杂志最近的两项研究报告表明,这种转化可以在心脏原位实现,并为心脏治疗药物的开发提供了一种新的、有前景的再生方法。

相似文献

1
In vivo reprogramming for heart disease.
Cell Res. 2012 Nov;22(11):1521-3. doi: 10.1038/cr.2012.101. Epub 2012 Jul 3.
2
Regenerative medicine: Reprogramming the injured heart.
Nature. 2012 May 31;485(7400):585-6. doi: 10.1038/485585a.
3
Heart repair by reprogramming non-myocytes with cardiac transcription factors.
Nature. 2012 May 13;485(7400):599-604. doi: 10.1038/nature11139.
4
Heart regeneration using reprogramming technology.
Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(3):118-28. doi: 10.2183/pjab.89.118.
7
Direct cardiac reprogramming: from developmental biology to cardiac regeneration.
Circ Res. 2013 Sep 13;113(7):915-21. doi: 10.1161/CIRCRESAHA.112.300625.
8
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.
Nature. 2012 May 31;485(7400):593-8. doi: 10.1038/nature11044.
9
The Promise of Cardiac Regeneration by In Situ Lineage Conversion.
Circulation. 2017 Mar 7;135(10):914-916. doi: 10.1161/CIRCULATIONAHA.116.025830.
10
Turning fibroblasts into cardiomyocytes: technological review of cardiac transdifferentiation strategies.
FASEB J. 2019 Jan;33(1):49-70. doi: 10.1096/fj.201800712R. Epub 2018 Sep 6.

引用本文的文献

1
Regulation of Cardiac Cell Fate by microRNAs: Implications for Heart Regeneration.
Cells. 2014 Oct 29;3(4):996-1026. doi: 10.3390/cells3040996.

本文引用的文献

1
Heart repair by reprogramming non-myocytes with cardiac transcription factors.
Nature. 2012 May 13;485(7400):599-604. doi: 10.1038/nature11139.
2
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5.
Circ Res. 2012 Jun 22;111(1):50-5. doi: 10.1161/CIRCRESAHA.112.270264. Epub 2012 May 10.
3
A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.
J Mol Cell Cardiol. 2012 Sep;53(3):323-32. doi: 10.1016/j.yjmcc.2012.04.010. Epub 2012 Apr 28.
4
MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes.
Circ Res. 2012 May 25;110(11):1465-73. doi: 10.1161/CIRCRESAHA.112.269035. Epub 2012 Apr 26.
5
Gene therapy for ventricular tachyarrhythmias.
Gene Ther. 2012 Jun;19(6):600-5. doi: 10.1038/gt.2012.35. Epub 2012 Apr 26.
6
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.
Nature. 2012 May 31;485(7400):593-8. doi: 10.1038/nature11044.
7
Towards regenerative therapy for cardiac disease.
Lancet. 2012 Mar 10;379(9819):933-942. doi: 10.1016/S0140-6736(12)60075-0.
8
A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine.
J Mol Cell Biol. 2012 Aug;4(4):190-6. doi: 10.1093/jmcb/mjs005. Epub 2012 Feb 27.
9
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.
Cell. 2010 Aug 6;142(3):375-86. doi: 10.1016/j.cell.2010.07.002.
10
Generation of functional ventricular heart muscle from mouse ventricular progenitor cells.
Science. 2009 Oct 16;326(5951):426-9. doi: 10.1126/science.1177350.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验